Trevi Therapeutics, Inc. — Director's Dealing 2021

Apr 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Trevi Therapeutics, Inc. (TRVI)
CIK: 0001563880
Period of Report: 2021-04-13

Reporting Person: Galletta Christopher (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-13	Stock Option (right to buy)	$2.53	A	25000	Acquired	2031-04-12	Common Stock (25000)	Direct

Footnotes

F1: This option was granted on April 13, 2021. The 25,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on April 12, 2022 and as to the remaining 75% of the shares in equal monthly installments thereafter, through April 12, 2025.